Tatva Chintan Pharma Chem Ltd reported Q2 FY 25 earnings with revenues at INR 835 million, down 14% year-on-year and 21% quarter-on-quarter, and EBITDA at INR 56 million, a 72% drop year-on-year and 56% decline quarter-on-quarter.
AI Assistant
Tatva Chintan Pharma Chem Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.